JNJ Analyst Ratings Thursday, October 15, 2026 +0.10 Neutral

Morgan Stanley Maintains Overweight on Johnson & Johnson, Lowers Price Target to $292

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed